70637-75-1 Usage
General Description
ETHYL 3-OXO-4-PIPERIDINECARBOXYLATE is a chemical compound with the molecular formula C9H15NO3. It is a white to off-white crystalline powder that is commonly used as an intermediate in the synthesis of pharmaceuticals and agrochemicals. ETHYL 3-OXO-4-PIPERIDINECARBOXYLATE is known for its versatile nature as it can be used in the production of various types of drugs and pesticides. It is also used in the research and development of new drugs due to its unique structural properties.ETHYL 3-OXO-4-PIPERIDINECARBOXYLATE has been approved by regulatory authorities for its use in various applications, including pharmaceutical manufacturing and research purposes.
Check Digit Verification of cas no
The CAS Registry Mumber 70637-75-1 includes 8 digits separated into 3 groups by hyphens. The first part of the number,starting from the left, has 5 digits, 7,0,6,3 and 7 respectively; the second part has 2 digits, 7 and 5 respectively.
Calculate Digit Verification of CAS Registry Number 70637-75:
(7*7)+(6*0)+(5*6)+(4*3)+(3*7)+(2*7)+(1*5)=131
131 % 10 = 1
So 70637-75-1 is a valid CAS Registry Number.
70637-75-1Relevant articles and documents
Stereocontrolled approach to quinuclidine derivatives
Da Silva Goes, Alexandre J.,Cave, Christian,D'Angelo, Jean
, p. 1339 - 1340 (1998)
Asymmetric Michael-type cyclization of chiral enamino ester (S)-7 furnished the quinuclidinone derivative (3R, 4S)-5, with a high degree of stereoselectivity.
PYRIMIDINYL TYROSINE KINASE INHIBITORS
-
Paragraph 0083, (2014/01/08)
The present invention provides compounds and compositions thereof which are useful as inhibitors of Bruton's tyrosine kinase and which exhibit desirable characteristics for the same.
PYRROLE DERIVATIVES WITH ANTIBACTERIAL ACTIVITY
-
Page/Page column 93-94, (2008/06/13)
Compounds of formula (I) and their pharmaceutically acceptable salts are described. Processes for their preparation, pharmaceutical compositions containing them, their use as medicaments and their use in the treatment of bacterial infections are also described.